國(guo)家(jia)食品(pin)藥品(pin)監管總局今(jin)天發(fa)布通知稱，在聽取了涉案(an)藥品(pin)的生產(chan)企業關于產(chan)品(pin)流向自(zi)查情況的匯報后(hou)，未發(fa)現(xian)涉案(an)藥品(pin)從藥品(pin)生產(chan)企業直接流入非(fei)法(fa)渠道。根據生產(chan)企業提供的信息，初步確認部(bu)分上下線線索人員身份。

　　國家(jia)食藥(yao)(yao)(yao)(yao)(yao)監(jian)總局指出，目前(qian)初步確認(ren)了山東省(sheng)食品(pin)藥(yao)(yao)(yao)(yao)(yao)品(pin)監(jian)管局公(gong)(gong)告(gao)中部分人員(yuan)的(de)身份(fen)：上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)82號(hao)牛自信為陜(shan)西醫(yi)(yi)(yi)(yi)維達康生(sheng)(sheng)物(wu)制(zhi)品(pin)有(you)(you)(you)(you)限(xian)(xian)責任公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)25號(hao)李留柱為南(nan)陽致遠生(sheng)(sheng)物(wu)醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)15號(hao)王忠林為貴州城海(hai)醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)4號(hao)張磊(lei)為安徽省(sheng)鷺燕大(da)華(hua)(hua)醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)78號(hao)張勇為成(cheng)都市仁(ren)邦醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)2號(hao)鄭健為安徽頤華(hua)(hua)藥(yao)(yao)(yao)(yao)(yao)業(ye)(ye)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)10號(hao)毛曉(xiao)琴為蘭州華(hua)(hua)衛藥(yao)(yao)(yao)(yao)(yao)品(pin)生(sheng)(sheng)物(wu)制(zhi)品(pin)有(you)(you)(you)(you)限(xian)(xian)責任公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)81號(hao)單(dan)二聯為陜(shan)西益康眾生(sheng)(sheng)醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)生(sheng)(sheng)物(wu)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)27號(hao)張昱為河南(nan)中聯醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)92號(hao)為濟寧福泰(tai)醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);上(shang)(shang)(shang)(shang)(shang)線(xian)(xian)(xian)(xian)第(di)(di)(di)16號(hao)高英(ying)祥為保(bao)定市保(bao)北醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)藥(yao)(yao)(yao)(yao)(yao)材有(you)(you)(you)(you)限(xian)(xian)責任公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan);下線(xian)(xian)(xian)(xian)第(di)(di)(di)131號(hao)王康友為陜(shan)西邦信生(sheng)(sheng)物(wu)醫(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)(xian)公(gong)(gong)司(si)業(ye)(ye)務(wu)(wu)(wu)員(yuan)。

　　藥品(pin)生(sheng)(sheng)產企(qi)業(ye)提(ti)供(gong)的多條線索還指向山東魯越生(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)有(you)限(xian)公(gong)司(si)(si)、河北(bei)省衛防(fang)生(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)供(gong)應(ying)中心、陜西益康(kang)(kang)眾生(sheng)(sheng)醫(yi)藥生(sheng)(sheng)物(wu)有(you)限(xian)公(gong)司(si)(si)、吉林尚元生(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)有(you)限(xian)公(gong)司(si)(si)、保(bao)(bao)定市(shi)保(bao)(bao)北(bei)醫(yi)藥藥材(cai)有(you)限(xian)責(ze)任(ren)(ren)公(gong)司(si)(si)、濟寧福泰醫(yi)藥有(you)限(xian)公(gong)司(si)(si)、陜西醫(yi)維(wei)達康(kang)(kang)生(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)有(you)限(xian)責(ze)任(ren)(ren)公(gong)司(si)(si)、南陽(yang)致遠生(sheng)(sheng)物(wu)醫(yi)藥有(you)限(xian)公(gong)司(si)(si)、四川(chuan)恒(heng)達生(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)有(you)限(xian)公(gong)司(si)(si)等藥品(pin)經(jing)營企(qi)業(ye)，表明上述企(qi)業(ye)可能是造成涉(she)案藥品(pin)流入非法渠道的主要責(ze)任(ren)(ren)單(dan)位。

　　“目前可以確定的(de)(de)是，涉(she)案(an)(an)疫(yi)(yi)苗都是正規企業(ye)的(de)(de)產品(pin)，產品(pin)本身是合格的(de)(de)。”國(guo)家食品(pin)藥(yao)品(pin)監管總局(ju)副(fu)局(ju)長(chang)吳湞(zhen)在23日上午舉(ju)辦的(de)(de)博鰲亞洲論壇“藥(yao)品(pin)審評(ping)審批制度改革(ge)”分論壇回應山東(dong)疫(yi)(yi)苗案(an)(an)時(shi)稱，這次非法經營疫(yi)(yi)苗案(an)(an)的(de)(de)核心(xin)問(wen)題是疫(yi)(yi)苗在存儲(chu)和運輸過程中出現了問(wen)題，脫離了冷鏈(lian)，這會造成疫(yi)(yi)苗效力減低，達不到預(yu)防(fang)疾病(bing)的(de)(de)效果(guo)。

　　為盡快查(cha)(cha)清非(fei)法經營疫苗(miao)涉案產品(pin)(pin)來源去向(xiang)，嚴懲違(wei)法犯罪行為，國(guo)家(jia)食品(pin)(pin)藥品(pin)(pin)監管總局(ju)已聯合公(gong)安(an)部(bu)、國(guo)家(jia)衛生(sheng)計(ji)生(sheng)委部(bu)署非(fei)法經營疫苗(miao)案件(jian)查(cha)(cha)處工作，要求根據山(shan)東(dong)省公(gong)布的(de)涉案嫌(xian)疑人員(yuan)名單(dan)和協(xie)查(cha)(cha)線(xian)索，對涉及(ji)(ji)(ji)本地區的(de)嫌(xian)疑人盡快核實身份(fen)，及(ji)(ji)(ji)時(shi)(shi)查(cha)(cha)明疫苗(miao)購銷(xiao)(xiao)(xiao)情(qing)況(kuang)。對屬(shu)于(yu)銷(xiao)(xiao)(xiao)售(shou)上線(xian)的(de)，應(ying)當(dang)查(cha)(cha)明銷(xiao)(xiao)(xiao)售(shou)單(dan)位(wei)和人員(yuan)以及(ji)(ji)(ji)銷(xiao)(xiao)(xiao)售(shou)的(de)品(pin)(pin)種(zhong)、生(sheng)產企業、批號、數(shu)量等情(qing)況(kuang);對屬(shu)于(yu)購進(jin)下線(xian)的(de)，應(ying)當(dang)查(cha)(cha)明購進(jin)單(dan)位(wei)和人員(yuan)以及(ji)(ji)(ji)購進(jin)的(de)品(pin)(pin)種(zhong)、生(sheng)產企業、批號、數(shu)量、銷(xiao)(xiao)(xiao)售(shou)去向(xiang)等情(qing)況(kuang)，同時(shi)(shi)做(zuo)好風險評(ping)估并采取相應(ying)措施。

　　“目前，我國疫苗流通過程中確實(shi)存(cun)在(zai)漏洞和不(bu)完善的地方。”吳湞表示(shi)，三(san)部委聯合辦案，一定會(hui)徹查案件(jian)，并且已(yi)經(jing)逐步公布涉(she)案的上下游人(ren)員和企業(ye)，接下來將對(dui)這(zhe)些(xie)涉(she)案方的相關情(qing)況進行(xing)深度(du)調查，在(zai)查實(shi)之(zhi)后，將對(dui)疫苗經(jing)營(ying)中的違(wei)法違(wei)規行(xing)為嚴厲(li)懲(cheng)處(chu)，不(bu)管是(shi)涉(she)及(ji)到單位、個(ge)人(ren)、企業(ye)還是(shi)機構，“涉(she)及(ji)到哪里處(chu)理(li)哪里，涉(she)及(ji)到誰處(chu)理(li)誰”。

　　同(tong)時，食藥監總局要求，相關(guan)省食品(pin)藥品(pin)監管局立即對相關(guan)藥品(pin)經營企業進(jin)行(xing)調查，徹(che)底(di)查清產(chan)品(pin)的流向，查實存在違(wei)(wei)法違(wei)(wei)規(gui)行(xing)為(wei)的，依法嚴肅懲處。調查結果于(yu)3月26日(ri)前上報(bao)食品(pin)藥品(pin)監管總局，由食品(pin)藥品(pin)監管總局統(tong)一向社會公開。更多最新數據分(fen)析(xi)、市場(chang)分(fen)析(xi)報(bao)告、市場(chang)調研、行(xing)業分(fen)析(xi)，請訪(fang)問。